Literature DB >> 17392036

Down-regulation of expression of rat pyruvate dehydrogenase E1alpha gene by self-complementary adeno-associated virus-mediated small interfering RNA delivery.

Zongchao Han1, Marina Gorbatyuk, James Thomas, Alfred S Lewin, Arun Srivastava, Peter W Stacpoole.   

Abstract

Mutations in the E1alpha subunit gene (PDHA1) of the pyruvate dehydrogenase complex (PDC) are common causes of congenital lactic acidosis. An animal model of E1alpha deficiency could provide insight into the pathological consequences of mutations and serve to test potential therapies. Small interfering RNAs (siRNAs) were designed to cleave the messenger RNA (mRNA) of the E1alpha subunit and were tested in vitro to assess the feasibility of producing a gene knockdown in rats. HEK 293 cells were co-transfected with a rat PDHA1 expression vector and eight naked siRNAs that specifically targeted rat E1alpha mRNA. Quantitative PCR (qPCR) analyses showed that four siRNAs reduced rat PDHA1 RNA levels up to 85% by 24h and up to 65% by 56h, compared to negative and positive controls. Since oligonucleotide-mediated siRNA delivery provided only transient suppression, we next selected two siRNA candidates and generated self-complementary, double-stranded adeno-associated virus (scAAV) vectors (serotypes 2 and 5) expressing a rat short hairpin siRNA expression cassette (scAAVsi-PDHA1). Rat lung fibroblast (RLF) cultures were infected with scAAVsi-PDHA1 vectors. The RLF PDHA1 mRNA level was reduced 53-80% 72h after infection and 54-70% 10 days after infection in RLF cultures. The expression of E1alpha and the specific activity of pyruvate dehydrogenase were also decreased at 10 days after infection in RLF cultures. Thus, scAAV siRNA-mediated knockdown of PDHA1 gene expression provides a strategy that may be applied to create a useful animal model of PDC deficiency.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17392036      PMCID: PMC1973157          DOI: 10.1016/j.mito.2007.02.003

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  21 in total

1.  A hybrid vector for ligand-directed tumor targeting and molecular imaging.

Authors:  Amin Hajitou; Martin Trepel; Caroline E Lilley; Suren Soghomonyan; Mian M Alauddin; Frank C Marini; Bradley H Restel; Michael G Ozawa; Catherine A Moya; Roberto Rangel; Yan Sun; Karim Zaoui; Manfred Schmidt; Christof von Kalle; Matthew D Weitzman; Juri G Gelovani; Renata Pasqualini; Wadih Arap
Journal:  Cell       Date:  2006-04-21       Impact factor: 41.582

2.  Role of cellular FKBP52 protein in intracellular trafficking of recombinant adeno-associated virus 2 vectors.

Authors:  Weihong Zhao; Li Zhong; Jianqing Wu; Linyuan Chen; Keyun Qing; Kirsten A Weigel-Kelley; Steven H Larsen; Weinian Shou; Kenneth H Warrington; Arun Srivastava
Journal:  Virology       Date:  2006-07-10       Impact factor: 3.616

Review 3.  Mutations in the X-linked pyruvate dehydrogenase (E1) alpha subunit gene (PDHA1) in patients with a pyruvate dehydrogenase complex deficiency.

Authors:  W Lissens; L De Meirleir; S Seneca; I Liebaers; G K Brown; R M Brown; M Ito; E Naito; Y Kuroda; D S Kerr; I D Wexler; M S Patel; B H Robinson; A Seyda
Journal:  Hum Mutat       Date:  2000       Impact factor: 4.878

Review 4.  Treatment of human disease by adeno-associated viral gene transfer.

Authors:  Kenneth H Warrington; Roland W Herzog
Journal:  Hum Genet       Date:  2006-04-13       Impact factor: 4.132

5.  Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system.

Authors:  Corinna Burger; Oleg S Gorbatyuk; Margaret J Velardo; Carmen S Peden; Philip Williams; Sergei Zolotukhin; Paul J Reier; Ronald J Mandel; Nicholas Muzyczka
Journal:  Mol Ther       Date:  2004-08       Impact factor: 11.454

6.  Mutations in the gene for the E1beta subunit: a novel cause of pyruvate dehydrogenase deficiency.

Authors:  Ruth M Brown; Rosemary A Head; Ivan I Boubriak; James V Leonard; Neil H Thomas; Garry K Brown
Journal:  Hum Genet       Date:  2004-05-11       Impact factor: 4.132

Review 7.  The pyruvate dehydrogenase complex as a target for gene therapy.

Authors:  Peter W Stacpoole; Renius Owen; Terence R Flotte
Journal:  Curr Gene Ther       Date:  2003-06       Impact factor: 4.391

8.  Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo.

Authors:  Z Wang; H-I Ma; J Li; L Sun; J Zhang; X Xiao
Journal:  Gene Ther       Date:  2003-12       Impact factor: 5.250

9.  Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo.

Authors:  D M McCarty; H Fu; P E Monahan; C E Toulson; P Naik; R J Samulski
Journal:  Gene Ther       Date:  2003-12       Impact factor: 5.250

10.  Circulating anti-wild-type adeno-associated virus type 2 (AAV2) antibodies inhibit recombinant AAV2 (rAAV2)-mediated, but not rAAV5-mediated, gene transfer in the brain.

Authors:  Carmen S Peden; Corinna Burger; Nicholas Muzyczka; Ronald J Mandel
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

View more
  6 in total

Review 1.  Self-complementary adeno-associated viral vectors for gene therapy of hemophilia B: progress and challenges.

Authors:  Deepak Raj; Andrew M Davidoff; Amit C Nathwani
Journal:  Expert Rev Hematol       Date:  2011-10       Impact factor: 2.929

2.  An animal model of PDH deficiency using AAV8-siRNA vector-mediated knockdown of pyruvate dehydrogenase E1α.

Authors:  Carolyn Ojano-Dirain; Lyudmyla G Glushakova; Li Zhong; Sergei Zolotukhin; Nicholas Muzyczka; Arun Srivastava; Peter W Stacpoole
Journal:  Mol Genet Metab       Date:  2010-07-15       Impact factor: 4.797

3.  A combined therapeutic approach for pyruvate dehydrogenase deficiency using self-complementary adeno-associated virus serotype-specific vectors and dichloroacetate.

Authors:  Zongchao Han; Kristen Berendzen; Li Zhong; Ira Surolia; Nitin Chouthai; Weihong Zhao; Njeri Maina; Arun Srivastava; Peter W Stacpoole
Journal:  Mol Genet Metab       Date:  2008-02-21       Impact factor: 4.797

Review 4.  Pulmonary delivery of therapeutic siRNA.

Authors:  Jenny Ka-Wing Lam; Wanling Liang; Hak-Kim Chan
Journal:  Adv Drug Deliv Rev       Date:  2011-02-26       Impact factor: 15.470

Review 5.  RNA interference: from basic research to therapeutic applications.

Authors:  Jens Kurreck
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

6.  AAV3-mediated transfer and expression of the pyruvate dehydrogenase E1 alpha subunit gene causes metabolic remodeling and apoptosis of human liver cancer cells.

Authors:  Lyudmyla G Glushakova; Matthew J Lisankie; Evgeniy B Eruslanov; Carolyn Ojano-Dirain; Irene Zolotukhin; Chen Liu; Arun Srivastava; Peter W Stacpoole
Journal:  Mol Genet Metab       Date:  2009-06-23       Impact factor: 4.797

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.